Novartis faces key meeting in US bribery scandal after settling corruption case | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Multimedia
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Saturday
December 09, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Multimedia
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
SATURDAY, DECEMBER 09, 2023
Novartis faces key meeting in US bribery scandal after settling corruption case

World+Biz

Reuters
26 June, 2020, 05:50 pm
Last modified: 26 June, 2020, 05:53 pm

Related News

  • How suspects laundered billions in Singapore for years
  • Vietnam arrests prominent parliamentary official as UN rights envoy visits
  • Poor governance hampers sustainable growth in Bangladesh, India, Pakistan: Experts
  • The missing rebuke: A family’s role in curbing corruption
  • 69.4% youth think nepotism, graft stifle development: Study

Novartis faces key meeting in US bribery scandal after settling corruption case

On Thursday, the US Department of Justice announced a $346 million agreement from Novartis to settle US criminal and civil charges that they bribed doctors, hospitals and clinics in Greece and Vietnam

Reuters
26 June, 2020, 05:50 pm
Last modified: 26 June, 2020, 05:53 pm
Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017/ Reuters
Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017/ Reuters

Swiss drugmaker Novartis, fresh from settling US charges over alleged kickbacks to doctors, is preparing for a key meeting next week with US prosecutors that could lead to the resolution of a decade-old bribery scandal.

On Thursday, the US Department of Justice announced a $346 million agreement from Novartis to settle US criminal and civil charges that they bribed doctors, hospitals and clinics in Greece and Vietnam.

While Novartis said the package resolves all its pending Foreign Corrupt Practices Act cases, another, potentially larger payment is looming: A decade-old whistleblower case in which the US government accuses it of paying millions in kickbacks to doctors to prescribe its drugs.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

A Novartis spokesman declined comment on a possible settlement and on its meeting with US prosecutors.

US District Court Judge Paul Gardephe has ordered a July 2 conference in that case, for both lawyers and the public, which would be the first court-ordered meeting in the matter since mid-2019 as the two sides discussed a settlement. Novartis has set aside $700 million.

Novartis's deal this week brings outlays in alleged corruption cases to about $1 billion over the last decade, and is a reminder of the Basel-based drugmaker's struggles to exit an era when it regularly tangled with prosecutors over its sales force's behavior.

"This is not good for the company's momentum," said Michael Nawrath, a Zuercher Kantonalbank analyst who rates Novartis shares "overweight." "Often Novartis is the one dealing with such breaches. We'll see to what extent Novartis will be free from future violations."

Novartis shares were down 0.13 percent, the worst performer on the Swiss benchmark index, with almost all other companies and the broader European Health Care index .SXDP trading positive by 1057 GMT.

Novartis Chief Executive Officer Vas Narasimhan has during his 2 1/2 year tenure had to grapple with what he has termed "legacy" ethics issues including fallout from hiring US President Donald Trump's ex-lawyer Michael Cohen as a consultant and US generics price fixing, which resulted in a $195 million settlement in March.

Novartis / Corruption

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Professor Wahiduddin Mahmud speaks at a public lecture session of the three-day Annual BIDS Conference on Development (ABCD) at a hotel in the capital on Saturday, 9 December. Photo: Courtesy
    Authoritarian regimes less equipped to align country's interest with their own: Prof Wahiduddin Mahmud
  • Infographics: Mehedi Hasan Marof/TBS
    Onion price nearly doubles overnight to Tk220 per kg
  • Mushfiqur takes legal action against Ekattor TV over 'false report'
    Mushfiqur takes legal action against Ekattor TV over 'false report'

MOST VIEWED

  • Buyer's rep removes sanction clause from RMG LC
    Buyer's rep removes sanction clause from RMG LC
  • Photo: Collected
    Dhaka expressway construction crane hits train; rail link with capital snapped
  • The company signed an agreement to this effect with BEPZA at BEPZA Complex, Dhaka on 7 December. Photo: Courtesy
    Chinese company to set up pharma ingredients factory in Bepza EZ
  • Infograph: TBS
    RMG exports to US fall 24.75% in Jan-Oct
  • One report says the suspects were stripped to ensure they were not carrying weapons - EMANUEL FABIAN/X/TWITTER
    Palestinians detained by Israel in Gaza blindfolded, stripped to underwear
  • Govt plans to downsize FY25 budget, cut growth targets
    Govt plans to downsize FY25 budget, cut growth targets

Related News

  • How suspects laundered billions in Singapore for years
  • Vietnam arrests prominent parliamentary official as UN rights envoy visits
  • Poor governance hampers sustainable growth in Bangladesh, India, Pakistan: Experts
  • The missing rebuke: A family’s role in curbing corruption
  • 69.4% youth think nepotism, graft stifle development: Study

Features

Tuhin Bin Salam has been at the helm of the business since his father died in 2017. Photo: Nayem Ali

60-year legacy: A chronicle of Salam Stamp Centre

9h | Panorama
Bangladesh now has 19 GI-certified products. What changed?

Bangladesh now has 19 GI-certified products. What changed?

1d | Panorama
Illustration: TBS

How financial institutions can help transition to net zero

1d | Panorama
Sketch: TBS

The looming populist dystopia

1d | Panorama

More Videos from TBS

US vetoes UN resolution for immediate humanitarian ceasefire in Gaza

US vetoes UN resolution for immediate humanitarian ceasefire in Gaza

12m | TBS World
McDonald’s unveils CosMc's trial

McDonald’s unveils CosMc's trial

2h | TBS World
Why are young people so eager to leave the country?

Why are young people so eager to leave the country?

4h | TBS Career
New morning, no home: The fragile nature of life on the climate frontline

New morning, no home: The fragile nature of life on the climate frontline

4h | TBS Stories
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]